The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence

BACKGROUND: Based on previous observations that the nutraceutical CELLFOOD™ (CF), the ‘physiological modulator’ that aimed to make oxygen available ‘on demand’, inhibits the growth of cancer cells, this study was designed to investigate the role of CF in the regulation of hypoxia-inducible factor 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuvoli, Barbara, Amadio, Bruno, Cortese, Giancarlo, Benedetti, Serena, Antoniani, Barbara, Soriani, Antonella, Carosi, Mariantonia, Strigari, Lidia, Galati, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792276/
https://www.ncbi.nlm.nih.gov/pubmed/31662796
http://dx.doi.org/10.1177/1758835919878347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792276/
https://www.ncbi.nlm.nih.gov/pubmed/31662796
http://dx.doi.org/10.1177/1758835919878347

Ejemplares similares